News China Approves Imipenem-Cilastatin-Funobactam: First BL/BLI Combination Targeting Three Major Carbapenem-Resistant Bacterial Groups DengYueMed, DengYue 17/11/2026
News FDA Approves Novel Chinese Drug Pimicotinib for Tenosynovial Giant Cell Tumor (TGCT) DengYueMed, DengYue 12/11/2026
News Lymphoma CAR-T Therapy IM19 Approved in China for Relapsed or Refractory LBCL DengYueMed, DengYue 10/11/2026
News Bayer’s Asundexian Approved in China: A Novel FXIa Inhibitor for Stroke Prevention DengYueMed, DengYue 29/10/2026
News New Drug Batoclimab for Myasthenia Gravis Approved in China, Advancing FcRn-Targeted Therapy DengYueMed, DengYue 24/10/2026
News Iberdomide Approved in China: The World’s First CELMoD Drug for Multiple Myeloma DengYueMed, DengYue 10/10/2026
News Sanofi’s Rilzabrutinib Approved in China: First BTK Inhibitor for Immune Thrombocytopenia (ITP) DengYueMed, DengYue 23/09/2026
News Innovative Lung Cancer Drug Asandeutertinib Approved: Deuterated Third-Generation EGFR-TKI for Brain Metastases DengYueMed, DengYue 18/09/2026
News Innovative Plaque Psoriasis Drug Lecankitug Approved: The World’s Second IL-17A/F Dual-Target Drug DengYueMed, DengYue 16/09/2026
News Innovative Multiple Myeloma Drug Velinotamig Approved in China for R/R Patients After Multiple Lines of Treatment DengYueMed, DengYue 05/09/2026
News Fanregratinib Approved for Intrahepatic Cholangiocarcinoma in China: A Novel Oral FGFR1/2/3 Inhibitor DengYueMed, DengYue 04/09/2026
News Icotrokinra Approved in China for Plaque Psoriasis: The World’s First Oral IL-23R-Targeted Drug DengYueMed, DengYue 28/08/2026